Cargando…

Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?

Detalles Bibliográficos
Autor principal:	Søreide, Kjetil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Needle Point
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364718/ https://www.ncbi.nlm.nih.gov/pubmed/34875032 http://dx.doi.org/10.1093/bjs/znab425

Ejemplares similares

Double trouble with double-booking: limitations and dangers of overlapping surgery
por: Pandit, Jaideep J, et al.
Publicado: (2022)

Effects of Rapid On-Site Evaluation on Diagnostic Accuracy of Thyroid Fine-Needle Aspiration
por: Fawcett, Celia, et al.
Publicado: (2022)

Risk of Malignancy Using the Diagnostic Categories Proposed by the World Health Organization International System for Reporting Pancreaticobiliary Cytopathology
por: Gocun, Pınar Uyar, et al.
Publicado: (2022)

Tubular Adenomas of the Breast Are Cytologically Distinct from Fibroadenomas
por: Li, Joshua J.X., et al.
Publicado: (2023)

Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?
por: Veen, Torhild, et al.
Publicado: (2017)

KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: A biomarker of cancer biology or a byproduct of patient selection?
por: Søreide, Kjetil, et al.
Publicado: (2014)

Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer
por: Chan, Gloria, et al.
Publicado: (2020)

Interventions for Individuals With High Levels of Needle Fear: Systematic Review of Randomized Controlled Trials and Quasi-Randomized Controlled Trials
por: McMurtry, C. Meghan, et al.
Publicado: (2015)

Perioperative Systemic Chemotherapy for Colorectal Liver Metastasis: Recent Updates
por: Lee, Hee Yeon, et al.
Publicado: (2021)

Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis
por: Søreide, Kjetil, et al.
Publicado: (2016)

Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials
por: Søreide, Kjetil
Publicado: (2016)

Far From “Just a Poke”: Common Painful Needle Procedures and the Development of Needle Fear
por: McMurtry, C. Meghan, et al.
Publicado: (2015)

Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases
por: Allard, M.‐A., et al.
Publicado: (2019)

Histopathological Growth Pattern in Colorectal Liver Metastasis and The Tumor Immune Microenvironment
por: Zaharia, Claudia, et al.
Publicado: (2022)

Hepatectomy versus Chemotherapy for Resectable Colorectal Liver Metastases in Progression after Perioperative Chemotherapy: Expanding the Boundaries of the Curative Intent
por: Famularo, Simone, et al.
Publicado: (2023)

Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis
por: Ono, Kosuke, et al.
Publicado: (2021)

Use of perioperative chemotherapy in colorectal cancer metastatic to the liver
por: Symonds, Lynn K, et al.
Publicado: (2019)

Morphological response contributes to patient selection for rescue liver resection in chemotherapy patients with initially un-resectable colorectal liver metastasis
por: Suzuki, Koichi, et al.
Publicado: (2017)

Simultaneous Resection of Primary Colorectal Cancer and Synchronous Liver Metastases: Contemporary Practice, Evidence and Knowledge Gaps
por: Kleive, Dyre, et al.
Publicado: (2021)

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing
por: Welsh, F K S, et al.
Publicado: (2007)

Immunoglobulin kappa chain as an immunologic biomarker of prognosis and chemotherapy response in solid tumors
por: Schmidt, Marcus, et al.
Publicado: (2012)

Pyrexia in Uncomplicated Cirrhosis of the Liver
Publicado: (1907)

Pyrexia in Malignant Disease of the Liver
Publicado: (1907)

Repeated Liver Resection for Colorectal Liver Metastases: A Comparison with Primary Liver Resections concerning Perioperative and Long-Term Outcome
por: Jönsson, Kristoffer, et al.
Publicado: (2012)

Putting a Halt to HALT: Does Anticoagulation Matter?
por: DeAnda, Abe, et al.
Publicado: (2022)

Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study
por: Rojas Llimpe, F L, et al.
Publicado: (2014)

Inflammation: The Straw That Broke the NAFLD Liver!
por: Raeman, Reben
Publicado: (2022)

Resection of colorectal liver metastases following neoadjuvant chemotherapy
por: Chiappa, A, et al.
Publicado: (2007)

Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer
por: Berg, Marianne, et al.
Publicado: (2011)

Reresection of Colorectal Liver Metastasis with Vena Cava Resection
por: Tardu, Ali, et al.
Publicado: (2016)

The roles of p27(Kip1) and DNA damage signalling in the chemotherapy-induced delayed cell cycle checkpoint
por: Liontos, Michalis, et al.
Publicado: (2010)

Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination
por: Litterman, Adam J, et al.
Publicado: (2013)

The Prussian Blue Reaction of the Liver in Pernicious Anæmia
Publicado: (1907)

Rebuttal to: Inflammation: The Straw That Broke the NAFLD Liver!
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022)

Liver Steatosis is a Driving Factor of Inflammation
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022)

The world economy will need even more globalization in the post-pandemic 2021 decade
por: Contractor, Farok J.
Publicado: (2021)

Neglected elements: What we should cover more of in international business research
por: Arikan, Ilgaz, et al.
Publicado: (2021)

The last frontier of globalization: Trade and foreign direct investment in healthcare
por: Shenkar, Oded, et al.
Publicado: (2021)

Testosterone Therapy for the Treatment of Age-Related Hypogonadism: Risks with Uncertain Benefits
por: Nguyen, Christine P., et al.
Publicado: (2021)

Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation
por: Tey, Siok-Keen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jjtr2f8frmuoej1frb4phftfu7